Literature DB >> 19544459

Embryonic stem cell-derived cardiomyogenesis: a novel role for calreticulin as a regulator.

Sylvia Papp1, Ewa Dziak, Michal Opas.   

Abstract

A role for calreticulin, an endoplasmic reticulum (ER)-resident, Ca(2+)-binding chaperone, has recently emerged in the context of cardiomyogenesis. We previously proposed calreticulin to be a novel cardiac fetal gene, because calreticulin knockout causes embryonic lethality in mice as a result of cardiac defects, it is transiently activated during heart development, and heart-targeted overexpression of constitutively active calcineurin in calreticulin-null mice rescues the lethal phenotype. Calreticulin affects Ca(2+) homeostasis and expression of adhesion-related genes. Using cardiomyocytes derived from both calreticulin-null and wild-type embryonic stem (ES) cells, we show here that cardiomyogenesis from calreticulin-null ES cells is accelerated but deregulated, such that the myofibrils of calreticulin-null cardiomyocytes become disorganized and disintegrate with time in culture. We have previously shown that the disorganization of the actin cytoskeleton in calreticulin-null cells may be explained, at least in part, by the downregulation of adhesion proteins, implying that calreticulin ablation causes adhesion-related defects. Here, upon examination of adhesion proteins, we found that vinculin is downregulated in calreticulin-null cardiomyocytes. We also found c-Src activity to be higher in calreticulin-null cardiomyocytes than in wild-type cardiomyocytes, and c-Src activity is affected by both calreticulin and [Ca(2+)]. Finally, we show that calreticulin and calsequestrin, the major Ca(2+) storage proteins of the ER and sarcoplasmic reticulum, respectively, exhibit alternate distributions. This suggests that calreticulin may have a housekeeping role to play in mature cardiomyocytes as well as during cardiomyogenesis. We propose here that calreticulin, an ER Ca(2+) storage protein, is a crucial regulator of cardiomyogenesis whose presence is required for controlled cardiomyocyte development from ES cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19544459     DOI: 10.1002/stem.85

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  10 in total

1.  Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype.

Authors:  Randolph S Faustino; Anca Chiriac; Nicolas J Niederlander; Timothy J Nelson; Atta Behfar; Prasanna K Mishra; Slobodan Macura; Marek Michalak; Andre Terzic; Carmen Perez-Terzic
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

2.  CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons.

Authors:  A Tefferi; T L Lasho; C M Finke; R A Knudson; R Ketterling; C H Hanson; M Maffioli; D Caramazza; F Passamonti; A Pardanani
Journal:  Leukemia       Date:  2014-01-09       Impact factor: 11.528

3.  Cytoskeletal disassembly and cell rounding promotes adipogenesis from ES cells.

Authors:  Tianshu Feng; Eva Szabo; Ewa Dziak; Michal Opas
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

4.  Calcineurin inhibitors exacerbate coronary arteritis via the MyD88 signalling pathway in a murine model of Kawasaki disease.

Authors:  K Murata; Y Motomura; T Tanaka; S Kanno; T Yano; M Onimaru; A Shimoyama; H Nishio; Y Sakai; M Oh-Hora; H Hara; K Fukase; H Takada; S Masuda; S Ohga; S Yamasaki; T Hara
Journal:  Clin Exp Immunol       Date:  2017-07-21       Impact factor: 4.330

5.  The effect of differentiation induction on FAK and Src activity in live HMSCs visualized by FRET.

Authors:  Xiaoling Liao; Shaoying Lu; Yiqian Wu; Wenfeng Xu; Yue Zhuo; Qin Peng; Bo Li; Ling Zhang; Yingxiao Wang
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

6.  The Mutation Profile of Calreticulin in Patients with Myeloproliferative Neoplasms and Acute Leukemia.

Authors:  Jingyi Wang; Jianguo Hao; Na He; Chunyan Ji; Daoxin Ma
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

7.  Modulation of chromatin remodeling proteins SMYD1 and SMARCD1 promotes contractile function of human pluripotent stem cell-derived ventricular cardiomyocyte in 3D-engineered cardiac tissues.

Authors:  Maggie Zi-Ying Chow; Stephanie N Sadrian; Wendy Keung; Lin Geng; Lihuan Ren; Chi-Wing Kong; Andy On-Tik Wong; Jean-Sebastien Hulot; Christopher S Chen; Kevin D Costa; Roger J Hajjar; Ronald A Li
Journal:  Sci Rep       Date:  2019-05-16       Impact factor: 4.379

8.  Inhibition of cardiomyocytes differentiation of mouse embryonic stem cells by CD38/cADPR/Ca2+ signaling pathway.

Authors:  Wen-Jie Wei; Hai-Ying Sun; Kai Yiu Ting; Li-He Zhang; Hon-Cheung Lee; Gui-Rong Li; Jianbo Yue
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

9.  Comparative differential proteomic profiles of nonfailing and failing hearts after in vivo thoracic aortic constriction in mice overexpressing FKBP12.6.

Authors:  Miresta Prévilon; Morgane Le Gall; Philippe Chafey; Christian Federeci; Mylène Pezet; Guilhem Clary; Cédric Broussard; Guillonneau François; Jean-Jacques Mercadier; Patricia Rouet-Benzineb
Journal:  Physiol Rep       Date:  2013-07-29

10.  Calreticulin Is Required for TGF-β-Induced Epithelial-to-Mesenchymal Transition during Cardiogenesis in Mouse Embryonic Stem Cells.

Authors:  Fereshteh Karimzadeh; Michal Opas
Journal:  Stem Cell Reports       Date:  2017-04-20       Impact factor: 7.765

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.